Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2018-01-25
Product name
Deferoxamine Mesylate for Injection (500 mg/Vial & 2 g/Vial)
Product Synonyms
N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl] propionamido]pentyl]-3-[[5-(N- hydroxyacetamido) pentyl] carbamoyl]propionohydroxamic acid
1.2.1 Relevant identified uses
Pharmaceutical product used as acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias
Manufacturer Name
Alvogen, Inc
Emergency telephone
1-844-842-8672
Icons in SDS
Company Information
company name
Alvogen, Inc
GHS Information
Signal word
Danger!
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H334, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335
May cause respiratory irritation
Section 2
SECTION 2: Hazards identification
1999/45/EC EMERGENCY OVERVIEW
Product definition
This product a white to off-white lyophilized powder or cake with no odor
Health hazards
May cause skin irritation or sensitization. Contact with eyes may cause irritation. Inhalation of dust may cause irritation and possible respiratory sensitization. Flammability Hazards: This product is non-flammable Reactivity Hazards: None known
Environmental hazards
The Environmental effects of this product have not been investigated. Release of this product is not expected to have significant adverse effects in the aquatic environment. US DOT SYMBOLS
Signal word
Danger!
Classification according to GHS
Skin Irritant Category 2 Skin Sensitizer Category 1 Eye Irritant Category 2 Respiratory Sensitizer Category 1 STOT SE Category 3
Precautionary statements
H315 – Causes skin irritation P260: Do not breathe dust/fume/mist/vapors/spray H317 – May cause allergic skin reaction P262: Do not get in eyes, on skin or on clothing H319 - Causes serious eye irritation P264: Wash skin after handling. H334 – May cause allergy or asthma symptoms or breathing difficulties if inhaled H335 – May cause respiratory irritation 2.3 HEALTH HAZARDS OR RISKS FROM EXPOSURE: SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The most significant routes of exposure for this product are by injection, ingestion, inhalation and skin or eye contact. ACUTE: May cause skin irritation or sensitization. Contact with eyes may cause irritation. Inhalation of dust may cause irritation and possible respiratory sensitization. CHRONIC: Ocular and auditory disturbances have been reported when deferoxamine mesylate was given over prolonged periods of time at high doses. TARGET ORGANS Acute Eyes, Skin, Respiratory System Chronic Eyes, Auditory
2.1 Classification of the substance or mixture
EUROPEAN UNION DIRECTIVES: This product does not meet the definition of a hazardous substance or preparation as defined by 29 CFR 1910. 1200 AND the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives. EU HAZARD CLASSIFICATION OF INGREDIENTS PER DIRECTIVE 1272/2008/EC: EC# 205-314-3 This substance is not classified in the Annex VI EC# 231-791-2 This substance is not classified in the Annex VI Substances not listed either individually or in group entries must be self classified. Component(s) Contributing to Classification(s) All Ingredients
